This inventor holds 138 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 30 EPO patents, primarily in LED Technology (CPC class H01L25-0753). Top assignees: Cree Gmbh, Know Bio, LLC, Creeled, Inc.. Active years: 2003-2026.
Inventors with similar research interests:
Location History:
- Durham, NC (US) (2003 - 2015)
- Chapel Hill, NC (US) (2008 - 2018)
- Raleigh, NC (US) (2014 - 2024)
- Atlanta, GA (US) (2021 - 2024)
Company Filing History:
115 out of 2,307 
18 out of 34 
4 out of 147 
Years Active: 2003-2026
Areas of Expertise:
Title: Michael John Bergmann: Pioneering Illumination Devices for Biological Effects
Introduction:
In the world of innovation and patents, Michael John Bergmann has made remarkable contributions through his groundbreaking inventions in the field of illumination devices. Based in Chapel Hill, NC (US), Bergmann has an impressive portfolio of 100 patents, with his latest inventions specifically focused on the induction of biological effects through illumination devices.
Biological Effects Illumination Devices:
Bergmann's recent patents revolve around the development of illumination devices that impinge light on tissue within a patient's body cavity, inducing various biological effects. These effects include inactivating and inhibiting growth of pathogens, upregulating local immune responses, increasing endogenous nitric oxide stores, releasing nitric oxide from endogenous sources, and inducing anti-inflammatory effects.
Tailored Light Treatments:
To achieve specific biological effects, Bergmann's illumination devices utilize different wavelengths of light, carefully chosen based on the desired outcome for targeted tissue types and pathogens. Moreover, these light treatments can provide multiple pathogenic biological effects, employing either a single wavelength or multiple wavelengths to enhance efficacy and reduce cytotoxicity.
Application in Upper Respiratory Tract Infections:
One remarkable aspect of Bergmann's work is the development of illumination devices that offer safe and effective treatments for upper respiratory tract infections. These devices have shown potential in combatting viruses from the coronaviridae and orthomyxoviridae families, paving the way for potential breakthroughs in the treatment of such infections.
Professional Collaborations:
Throughout his distinguished career, Bergmann has collaborated with industry leaders to further his research and innovation. Notably, he has worked with CreeLED, Inc. and KNOW Bio, LLC, companies recognized for their contributions to the field of illumination and biotechnology. His collaborations with colleagues such as David T Emerson and Kevin Haberern have fostered a dynamic environment for innovative development and cutting-edge inventions.
Conclusion:
Michael John Bergmann stands as a leading innovator in the realm of illumination devices, with an impressive record of 100 patents and a focus on inducing biological effects. His work showcases the potential to revolutionize treatments for various ailments, including upper respiratory tract infections, and holds promise for advancing medical solutions. Bergmann's collaborations with renowned companies and colleagues demonstrate his commitment to pushing the boundaries of innovation, ultimately improving the lives of individuals worldwide through his extraordinary inventions.